Community-based approaches to HIV treatment in resource-poor settings (Q44511047)

3 December 2017

Community-based approaches to HIV treatment in resource-poor settings (English)

1 reference

3 December 2017

8

1 reference

3 December 2017

6

M C Smith-Fawzi

1 reference

3 December 2017

P Farmer

1

1 reference

3 December 2017

F Léandre

2

1 reference

3 December 2017

J S Mukherjee

3

1 reference

3 December 2017

M Claude

4

1 reference

3 December 2017

P Nevil

5

1 reference

3 December 2017

S P Koenig

7

1 reference

3 December 2017

M C Becerra

9

1 reference

3 December 2017

J Sachs

10

1 reference

3 December 2017

A Attaran

11

1 reference

3 December 2017

J Y Kim

12

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

3 December 2017

1 reference

3 December 2017

358

1 reference

3 December 2017

404-409

1 reference

3 December 2017

9279

1 reference

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

Natural history of HIV infection in the era of combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

Advances in control of sexually transmitted diseases in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

A prospective study of HIV-seropositive asymptomatic women of childbearing age in a developing country.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

Costs of HIV medical care in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

Clinical factors associated with weight loss related to infection with human immunodeficiency virus type 1 in the Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

Frequencies of opportunistic diseases prior to death among HIV-infected persons. Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

Access to essential drugs in poor countries: a lost battle?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

Assessment of worldwide tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

When tuberculosis treatment fails. A social behavioral account of patient adherence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus".

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

Editorial: Rifampicin or ethambutol in the routine treatment of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

The cost effectiveness of combination antiretroviral therapy for HIV disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905550-7

7 January 2021

10.1016/S0140-6736(01)05550-7

Identifiers

DOI

1 reference

3 December 2017

1 reference